Status:

UNKNOWN

Integrated Neuromuscular Inhibition Versus Instrument Assisted Soft Tissue Mobilization in Chronic Back Pain

Lead Sponsor:

Cairo University

Conditions:

Chronic Non Specific Low Back Pain

Eligibility:

All Genders

18-30 years

Phase:

NA

Brief Summary

this study will be conducted to identify the difference between the effect of integrated neuromuscular inhibition technique and instrument assisted soft tissue mobilization on back pain, pain threshol...

Eligibility Criteria

Inclusion

  • 1\. The patient's age ranged from 18 to 30 years.(Geogre et al, 2021) 2. Patients with low back pain for more than 3 months (pain felt between T12 and the gluteal fold).
  • 3\. Patient with chronic low back pain 4. Normal body mass index from 18 -25kg/m2.

Exclusion

  • The subjects will be excluded if they have any of the followings:
  • Lumbar discogenic lesions or any inflammatory arthritis, tumors, infection involving the lumbar spine.
  • Patients with decreased range of motion secondary to congenital anomalies, muscular contracture, or bony block.
  • Previous lumbar or hip surgery or trauma.
  • Any hip structural abnormality such as malformations, impingements and degeneration.
  • Patients With cognitive impairments that would limit their participation

Key Trial Info

Start Date :

November 1 2023

Trial Type :

INTERVENTIONAL

Allocation :

ESTIMATED

End Date :

March 1 2024

Estimated Enrollment :

45 Patients enrolled

Trial Details

Trial ID

NCT06116058

Start Date

November 1 2023

End Date

March 1 2024

Last Update

November 3 2023

Active Locations (0)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 0 (0 locations)

No Results Found

We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.